(Press-News.org) The human immune system can handle large bursts of HIV activity and so it should be possible to cure HIV with a 'kick and kill' strategy, finds new research led by UCL, the University of Oxford and the University of North Carolina at Chapel Hill.
The 'kick and kill' strategy aims to cure HIV by stimulating the immune system with a vaccine, then re-awakening dormant HIV hiding in white blood cells with a chemical 'kick' so that the boosted immune system can identify and kill them.
While this approach is promising in theory, it was previously unclear whether the human immune system would be able to control HIV following full-blown reactivation of the virus. The new research, published in Clinical Infectious Diseases, demonstrates that this is possible using a single patient case study.
"Our study shows that the immune system can be as powerful as the most potent combination drug cocktails," explains study co-author Dr Ravi Gupta (UCL Infection & Immunity). ". We're still a long way from being able to cure HIV patients, as we still need to develop and test effective vaccines, but this study takes us one step closer by showing us what type of immune responses an effective vaccine should induce."
The study looked at a single 59 year old man in London who was an 'elite controller', meaning that his immune system could control HIV for a long time without needing treatment. Elite controllers, who make up 0.3% of HIV patients, eventually require treatment to prevent progression to AIDS but they can go a lot longer without treatment because their immune systems are more active against HIV.
The patient in the study had both HIV and myeloma, a cancer of the bone marrow. The bone marrow produces white blood cells, including those that help to control HIV. To treat the patient's myeloma, his bone marrow was completely removed and replaced using his own stem cells. When the bone marrow was removed, the immune system was severely impaired, allowing the HIV to re-activate and replicate. This caused the level of virus in his bloodstream to rise from fewer than 50 copies per millilitre to approximately 28,000 copies per ml before immune function returned.
When the patient's immune function returned about two weeks after the transplant, the levels of HIV in his bloodstream rapidly fell. His immune system reduced HIV levels at a similar rate to the most powerful treatments available, bringing them back down to 50 copies per ml within six weeks.
"By measuring the strength of the immune system required to keep this virus under control in this rare individual, we have a better idea of the requirements for successful future treatment," says co-author Professor Deenan Pillay (UCL Infection & Immunity, and now also Director of the Africa Centre for Health and Population Studies, in South Africa). "We also managed to identify the specific immune cells that fought the infection. This is a single patient study, but nevertheless it is often the unusual patients who help us to understand the HIV disease process."
The patient was not given anti-HIV medication in this study due to concerns about side-effects affecting the myeloma treatment and low initial levels of HIV in his bloodstream. It is possible that an equally strong immune response in combination with powerful drugs could have cured the HIV completely, however this is far from certain.
"We need to be cautious in interpreting observations from a single subject," says Dr Nilu Goonetilleke, who began working on the study at the University of Oxford and is now at the University of North Carolina at Chapel Hill. "However, demonstration even from a single subject, that our immune system can rapidly control HIV-1 tells us a lot about the types of immune responses we should target and augment through vaccination."
Dr Gupta adds: "Drugs to stimulate reactivation of dormant HIV are still imperfect, and we do not know if they would be able to flush out all of the HIV from the body. Likewise, it remains to be seen whether a vaccine could enable a normal HIV patient's immune system to kill HIV with the full strength of an elite controller. Our study is a proof of principle and the results are promising, but it is unlikely to lead to a cure for at least a decade."
INFORMATION:
Silicon based chips and transistors have been at the heart of all electronic devices since the 1950s. Driven by economic and environmental factors, and by the need for renewable energy resources, there is currently an enormous scientific and technological interest in transitioning away from silicon based electronics to new organic electronic devices. Just like living organisms, organic electronics use carbon in complex molecules as their key functional component. These new organic electronic devices are less expensive, more environmentally friendly and better recyclable ...
ANN ARBOR--University of Michigan researchers have discovered a biomarker that may be a potentially important breakthrough in diagnosing and treating prostate cancer.
Biomarkers in the body are analogous to the warning lights in cars that signal something might need repairing. In our bodies, they indicate if something's wrong or if we're about to get sick or if we're predisposed to certain illnesses.
"(In the context of prostate cancer) there's a big interest in trying to find biomarkers to discriminate between aggressive and nonaggressive disease," said Renny Franceschi, ...
As part of the PlanetS National Centre of Competence in Research (NCCR), astronomers from the Universities of Geneva (UNIGE) and Bern, Switzerland, have come to measure the temperature of the atmosphere of an exoplanet with unequalled precision, by crossing two approaches. The first approach is based on the HARPS spectrometer and the second consists of a new way of interpreting sodium lines. From these two additional analyses, researchers have been able to conclude that the HD189733b exoplanet is showing infernal atmospheric conditions: wind speeds of more than 1000 kilometres ...
A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts at the back of the throat and mouth, and involves the tonsils and base of the tongue. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study provides important information about HPV vaccination, which has proven effective against HPV-related disease in both sexes but remains controversial, especially in males.
Many western countries ...
This news release is available in Portuguese. Cancer patients are more likely to get infections. Pneumonia is the most frequent type of infection in this group and a frequent cause of ICU admission and mortality. A study conducted by researchers from the D'Or Institute for Research and Education (IDOR) in partnership with Brazilian hospitals and universities analyzed the factors associated with severe pneumonia in hospitalized cancer patients and suggests that more personalized treatment protocols can reduce mortality in these patients.
Until now, there was a consensus ...
Telomeres are short stretches of repeated nucleotides that protect the ends of chromosomes. In somatic cells, these protective sequences become shorter with each cellular replication until a critical length is reached, which can trigger cell death.
In actively replicating cells such as germ cells, embryonic stem cells, and blood stem cells of the bone marrow, the enzyme telomerase replenishes these protective caps to ensure adequate replication. Cancer cells also seem to have the ability to activate telomerase, which allows them to keep dividing indefinitely, with ...
Washington, D.C. - April 10, 2015 - Human norovirus may infect our canine companions, according to research published online April 1 in the Journal of Clinical Microbiology, a publication of the American Society for Microbiology. That raises the possibility of dog-to-human transmission, said first author Sarah Caddy, VetMB, PhD, MRCVS, a veterinarian and PhD student at the University of Cambridge, and Imperial College, London, UK. Norovirus is the leading cause of food-borne illness in the United States, according to the Centers for Disease Control and Prevention (CDC). ...
CHICAGO (April 9, 2015): The Affordable Care Act (ACA) allowed millions of young adults to retain health care coverage through their parents' insurance plans, but new research finds that many young African-American and Hispanic adults who need coverage for trauma care may not get it. The results of the study are published online as an "article in press" in the Journal of the American College of Surgeons and will appear in a print edition later this year.
Before the dependent care provision of the Affordable Care Act became law in September 2010, approximately 30 percent ...
Certain types of supernovae, or exploding stars, are more diverse than previously thought, a University of Arizona-led team of astronomers has discovered. The results, reported in two papers published in the Astrophysical Journal, have implications for big cosmological questions, such as how fast the universe has been expanding since the Big Bang.
Most importantly, the findings hint at the possibility that the acceleration of the expansion of the universe might not be quite as fast as textbooks say.
The team, led by UA astronomer Peter A. Milne, discovered that type ...
Middle-aged people who are underweight (with a Body Mass Index [BMI] less than 20 kg/m2 [1]) are a third more likely to develop dementia than people of similar age with a healthy BMI, according to new research published in The Lancet Diabetes & Endocrinology journal.
The findings, which come from the largest ever study to examine the statistical association between BMI and dementia risk, also show that middle-aged obese people (BMI greater than 30 kg/m2) are nearly 30% less likely to develop dementia than people of a healthy weight, contradicting findings from some previous ...
